Weng J, Huang A, Berake TB, Chen SL, Yan BM, Karagozian R. Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterol Res [Internet]. 2026 Jan. 1 [cited 2026 Jun. 17];19(3):147-54. Available from: https://gr.elmerpub.com/index.php/gr/article/view/2136